190 related articles for article (PubMed ID: 23945797)
1. Risk factors for early readmission to acute care for persons with schizophrenia taking antipsychotic medications.
Boaz TL; Becker MA; Andel R; Van Dorn RA; Choi J; Sikirica M
Psychiatr Serv; 2013 Dec; 64(12):1225-9. PubMed ID: 23945797
[TBL] [Abstract][Full Text] [Related]
2. Hospitalization resource utilization and costs among Medicaid insured patients with schizophrenia with different treatment durations of long-acting injectable antipsychotic therapy.
Bera R; Offord S; Zubek D; Lau G; Lin J; Karson C
J Clin Psychopharmacol; 2014 Feb; 34(1):30-5. PubMed ID: 24135840
[TBL] [Abstract][Full Text] [Related]
3. Psychotropic medication changes, polypharmacy, and the risk of early readmission in suicidal adolescent inpatients.
Fontanella CA; Bridge JA; Campo JV
Ann Pharmacother; 2009 Dec; 43(12):1939-47. PubMed ID: 19934394
[TBL] [Abstract][Full Text] [Related]
4. Favorable bed utilization and readmission rates for emergency department observation unit heart failure patients.
Schrager J; Wheatley M; Georgiopoulou V; Osborne A; Kalogeropoulos A; Hung O; Butler J; Ross M
Acad Emerg Med; 2013 Jun; 20(6):554-61. PubMed ID: 23758301
[TBL] [Abstract][Full Text] [Related]
5. The association of acute kidney injury in the critically ill and postdischarge outcomes: a cohort study*.
Horkan CM; Purtle SW; Mendu ML; Moromizato T; Gibbons FK; Christopher KB
Crit Care Med; 2015 Feb; 43(2):354-64. PubMed ID: 25474534
[TBL] [Abstract][Full Text] [Related]
6. Thirty-Day Hospital Readmission for Medicaid Enrollees with Schizophrenia: The Role of Local Health Care Systems.
Busch AB; Epstein AM; McGuire TG; Normand SL; Frank RG
J Ment Health Policy Econ; 2015 Sep; 18(3):115-24. PubMed ID: 26474051
[TBL] [Abstract][Full Text] [Related]
7. The effect of adjunctive mood stabilizers on antipsychotic utilization pattern and health resource utilization for Medicaid enrollees with schizophrenia.
Chen H; Kennedy WK; Dorfman JH; Fincham JE; Reeves J; Martin BC
Curr Med Res Opin; 2007 Jun; 23(6):1351-65. PubMed ID: 17559734
[TBL] [Abstract][Full Text] [Related]
8. Outpatient antipsychotic treatment and inpatient costs of schizophrenia.
Marcus SC; Olfson M
Schizophr Bull; 2008 Jan; 34(1):173-80. PubMed ID: 17578893
[TBL] [Abstract][Full Text] [Related]
9. Early non-adherence to medication and other risk factors for rehospitalization in schizophrenia and schizoaffective disorder.
Bodén R; Brandt L; Kieler H; Andersen M; Reutfors J
Schizophr Res; 2011 Dec; 133(1-3):36-41. PubMed ID: 21982098
[TBL] [Abstract][Full Text] [Related]
10. A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia.
Tiihonen J; Haukka J; Taylor M; Haddad PM; Patel MX; Korhonen P
Am J Psychiatry; 2011 Jun; 168(6):603-9. PubMed ID: 21362741
[TBL] [Abstract][Full Text] [Related]
11. Hospital Readmission Rates Among Patients With Schizophrenia Treated With Long-Acting Injectables or Oral Antipsychotics.
MacEwan JP; Kamat SA; Duffy RA; Seabury S; Chou JW; Legacy SN; Hartry A; Eramo A; Karson C
Psychiatr Serv; 2016 Nov; 67(11):1183-1188. PubMed ID: 27417897
[TBL] [Abstract][Full Text] [Related]
12. Childhood Asthma Hospital Discharge Medication Fills and Risk of Subsequent Readmission.
Kenyon CC; Rubin DM; Zorc JJ; Mohamad Z; Faerber JA; Feudtner C
J Pediatr; 2015 May; 166(5):1121-7. PubMed ID: 25641244
[TBL] [Abstract][Full Text] [Related]
13. Assessment of inpatient psychiatric readmission risk among patients discharged on an antipsychotic polypharmacy regimen: A retrospective cohort study.
Boskailo E; Malkoc A; McCurry DB; Venter J; Drachman D; Ramos GM
Acta Med Acad; 2017 Nov; 46(2):133-144. PubMed ID: 29338277
[TBL] [Abstract][Full Text] [Related]
14. Association between second-generation antipsychotic medication half-life and hospitalization in the community treatment of adult schizophrenia.
Broder MS; Bates JA; Jing Y; Hebden T; Forbes RA; Chang E
J Med Econ; 2012; 15(1):105-11. PubMed ID: 21991926
[TBL] [Abstract][Full Text] [Related]
15. Risperidone long-acting therapy prescribing patterns and their impact on early discontinuation of treatment in a large Medicaid population.
Boaz TL; Constantine RJ; Robst J; Becker MA; Howe AM
J Clin Psychiatry; 2011 Aug; 72(8):1079-85. PubMed ID: 21034690
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care.
Stargardt T; Weinbrenner S; Busse R; Juckel G; Gericke CA
J Ment Health Policy Econ; 2008 Jun; 11(2):89-97. PubMed ID: 18509216
[TBL] [Abstract][Full Text] [Related]
17. Rehospitalization risk factors for psychiatric treatment among elderly Medicaid beneficiaries following hospitalization for a physical health condition.
Boaz TL; Becker MA; Andel R; McCutchan N
Aging Ment Health; 2017 Mar; 21(3):297-303. PubMed ID: 26523783
[TBL] [Abstract][Full Text] [Related]
18. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.
Morrato EH; Dodd S; Oderda G; Haxby DG; Allen R; Valuck RJ
Clin Ther; 2007 Jan; 29(1):183-95. PubMed ID: 17379060
[TBL] [Abstract][Full Text] [Related]
19. Risk factors of 30-days re-hospitalization after Hospital at Home in a cohort of patients treated with parenteral therapy.
Cramer S; Fonager K
Eur J Intern Med; 2014 Dec; 25(10):895-9. PubMed ID: 25468737
[TBL] [Abstract][Full Text] [Related]
20. Predictors of short-term rehospitalization following discharge of patients hospitalized with community-acquired pneumonia.
Capelastegui A; España Yandiola PP; Quintana JM; Bilbao A; Diez R; Pascual S; Pulido E; Egurrola M
Chest; 2009 Oct; 136(4):1079-1085. PubMed ID: 19395580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
